Human insulin-induced lipoatrophy.
Felner
Eric I
EI
Pediatric Endocrinology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D061268:Insulin Lispro; D007336:Insulin, Isophane / Q000009:adverse effects* / Q000627:therapeutic use*; D008060:Lipodystrophy / Q000139:chemically induced* / Q000473:pathology; D008297:Male
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro; D007336:Insulin, Isophane